Arnhold LLC’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Arnhold LLC’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-84,600	Closed	-$3.54M	–	152
2018 Q1	$3.54M	Buy	+84,600	New	+$3.69M	0.67%	50

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $45.3M AUM 42.75% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Arnhold LLC's XPH Position: Q2 2018 in Review

Arnhold LLC sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 84,600 shares — an estimated $3.54M sold.

Arnhold LLC first reported a position in XPH in Q1 2018 and held it in 1 quarter. The position peaked at $3.54M in Q1 2018. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

Arnhold LLC reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Arnhold LLC sold 84,600 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $3.54M.
Arnhold LLC first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2018 and held it in 1 quarter.
Arnhold LLC's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.54M in Q1 2018.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on Arnhold LLC's 13F filing for Q2 2018, filed 14 Aug 2018.